- 米国企業
- Stoke Therapeutics, Inc.
Stoke Therapeutics, Inc.STOK
時価総額
$6.2億
PER
2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | |
Revenue | - | - | - | 12 |
Research and development | 24 | 32 | 54 | 78 |
General and administrative | 12 | 21 | 32 | 39 |
Total operating expenses | 36 | 53 | 86 | 117 |
Loss from operations | -36 | -53 | -86 | -104 |
Interest income (expense), net | - | - | 0 | 3 |
Other income (expense), net | 0 | 0 | 0 | 0 |
Total other income (expense) | 3 | 1 | 0 | 3 |
Net loss | -32 | -52 | -86 | -101 |
Earnings Per Share Basic | - | - | - | -2.6 |
Earnings Per Share Diluted | - | - | - | -2.6 |
Net loss | -32 | -52 | -86 | -101 |
Unrealized loss on marketable securities | - | - | -0 | -1 |
Total other comprehensive loss | - | - | -0 | -1 |
Comprehensive loss | - | - | -86 | -102 |